GJE client OncoImmunity AS acquired by NEC Corporation

OncoImmunity AS has been acquired by renowned Japanese IT and network company, NEC Corporate. OncoImmunity AS develops software that identifies neoantigen targets for truly personalized cancer vaccines, cell therapies and...

Read more


Advances in Gene Therapy: The End of the Era of Incurable Genetic Diseases?

Categories: Biotechnology

Editing an individual’s DNA, to prevent or treat a genetic disease, at one time seemed an impossible task. Remarkably, we are now living in an age of medical development where...

Read more

Legal Updates

Shining a light on evidence at the UK IPO

With Brexit approaching and companies insuring against the uncertainty that brings there has been a steady uptick in registered design filings over the last three years. This may ultimately lead...

Read more


Notes from a Digital Nomad – Month 13: Epilogue

In a way, it does feel a bit like I’ve been in outer space for the past year – communicating with ground control in London via the digital ether; living...

Read more


GJE Proud to Sponsor GIANT Health 2019

We are proud to sponsor GIANT Health 2019. GIANT Health, taking place at Stamford Bridge, London, on 15 – 16 October 2019, is Europe’s largest health-tech event and will welcome...

Read more